Human Reproductive Technologies Market Synopsis:
Human Reproductive Technologies Market Size Was Valued at USD 34.7 Billion in 2023, and is Projected to Reach USD 81.15 Billion by 2032, Growing at a CAGR of 9.90% From 2024-2032.
HRT market primarily includes over 100 modern healthcare services and products aimed at assisting human procreation and consist of IVF, IAI, PGD/PGS, surrogacy, etc. These technologies are used in childless cases to produce a child when normal child bearing cannot be accomplished or is not fruitful. Several factors ranging from evolvement in medical field and development of fertility treatment techniques the market embrace high demand for fertility treatments enhanced by research on techniques that enhance success rates and reduce complications.
High infertility rates have become the primary motivator of the Human Reproductive Technologies market. Things like late marriages, no exercise, stress, and environmental pollutants are causing increase in infertility as experienced in the advance nations. With more and more people becoming open to in vitro fertilization, more patients are looking for more sophisticated treatments; thus, expanding the market.
Also, improvement of medical technologies and equities to fertility clinics has also boosted the market growth. Technological advancements such as the genetic test, embryo preservation and minimal invasive surgery are increasing treatment outcomes which in turn increases the technology adoption by the health facility. Some of the other supports also coming from the government and healthcare organizations that offer insurance plans for those fertility treatments would also increase the market size.
Human Reproductive Technologies Market Trend Analysis:
Increasing demand for genetic screening and embryo editing
- Another emerging trend of the Human Reproductive Technologies market is founding genetic screening and embryo editing. By selecting optimistic embryos which were screened in preimplantation genetic testing (PGT) expectant parents increases their probabilities of desired pregnancy and healthy offspring. It is also promoting ethical discourses over genetic engineering and selection as well as the regulatory discourses.
- The third focal area is increases in fertility preservation, such as egg and sperm freezing. This makes fertility preservation increasingly popular among women who decide to postpone the start of a family for any reason. This trend is being boosted by exam proved technique in which the eggs and sperms are preserved and this has led to increase in women’s fertility period.
Increase in the number of individuals seeking fertility services
- The increasing use of fertility treatments in the emerging markets has provided the Human Reproductive Technologies market with a strategic opportunity. Emerging economies of Asia-Pacific, Latin America and African nations are seeing an upsurge of people using fertility services owing to change in mind-sets and improved access to health care services. Clinics and individual healthcare providers can seek to exploit these markets by providing reproductive solutions in accord with these locations.
- Also, the increasing tendency towards surrogacy on behalf of international providers, including the United States and India, can be seen as further potential for clinics and legal assistance related to reproductive technologies. Since surrogacy laws are becoming liberalized and more couples are demanding surrogate mothers, there should be an increase in demand for services which form the basis of surrogacy therefore providing an added source of income to the HRT industry.
Human Reproductive Technologies Market Segment Analysis:
Human Reproductive Technologies Market Segmented on the basis of Technology, Procedure, Application, End User, and Region
By Technology, Surrogacy segment is expected to dominate the market during the forecast period
- The Human Reproductive Technologies market comprises: Assisted Reproductive Technology (ART) In-Vitro fertilization (IVF) Surrogacy Artificial insemination Genetic testing ART includes such techniques as fertility therapies meant to assist persons to achieve pregnancy such as IVF, where an egg harvested and fertilized with sperm externally, the developed embryo, is inserted into the uterus. Surrogacy means that another woman has to give birth to a child for others, if a woman cannot do this herself. Artificial Insemination means the act of depositing sperm directly into a woman’s reproductive system to ensure pregnancy. Genetic testing is utilized to diagnose genetic disorders or anatomical irregularities in embryos before they are put into the uterus, in order to have healthy pregnancies. These technologies have brought a new pace in fertility treatments, which has become a hope to the people with fertility problems.
By Application, Male Infertility segment expected to held the largest share
- The applications of the Human Reproductive Technologies market include; male infertility, female infertility, and genetic disorders. Some of the treatment methods used in case of male infertility include sperm pick up, artificial insemination, IVF- ICSI where case of low sperm density or poor sperm mobility is a challenge. There are different types of infertility treatments in women including; IVF, egg donation and embryo freezing depending on the factors such as ovulation disorders, blocked fallopian tubes, or irregular shape/position of uterus or even endometriosis. Furthermore, current and innovative methods, in a way, attempt to prevent genetic disorders by means of preimplantation genetic testing (PGT) which enables the selection of embryos having no inherited conditions and, thereby, contribute to an improved pregnancy and a low rate of inheriting disease. Such applications meet the requirements of people and couples who need help in reproduction.
Human Reproductive Technologies Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North America now has the largest share in the Human Reproductive Technologies market, and the United States has the highest demand. High health care index, development of medical science, and many fertility clinics are advantageous for the region. Further, growth in awareness levels about fertility treatments and insurance cover especially for some of these treatments’ fosters market growth in this regional segment. An established clinic, the participation of the top providers of fertility treatment facilities, and the uninterrupted improvement of the technologies make North America the global leader in the market.
- Moreover, the increased rate of infertility and the trend where people delay having children put the high demand for assisted reproductive technologies, which guarantees the hegemony of North America. It has many fertility centers/clinics with state-of-the-art services; has good legislation on enabling new technologies in the area of reproduction.
Active Key Players in the Human Reproductive Technologies Market:
- Boston IVF (United States)
- CooperSurgical (United States)
- Ferring Pharmaceuticals (Switzerland)
- Genea (Australia)
- IVF Life (Spain)
- LifeCell (India)
- Merck KGaA (Germany)
- Ovation Fertility (United States)
- The ART Fertility Clinics (United States)
- Thermo Fisher Scientific (United States)
- Other Active Players
|
Human Reproductive Technologies Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 34.7 Billion |
|
Forecast Period 2024-32 CAGR: |
9.90% |
Market Size in 2032: |
USD 81.15 Billion |
|
Segments Covered: |
By Technology |
|
|
|
By Procedure |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Human Reproductive Technologies Market by Technology
4.1 Human Reproductive Technologies Market Snapshot and Growth Engine
4.2 Human Reproductive Technologies Market Overview
4.3 Assisted Reproductive Technology (ART)
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Assisted Reproductive Technology (ART): Geographic Segmentation Analysis
4.4 In Vitro Fertilization (IVF)
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 In Vitro Fertilization (IVF): Geographic Segmentation Analysis
4.5 Surrogacy
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Surrogacy: Geographic Segmentation Analysis
4.6 Artificial Insemination
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Artificial Insemination: Geographic Segmentation Analysis
4.7 Genetic Testing
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Genetic Testing: Geographic Segmentation Analysis
Chapter 5: Human Reproductive Technologies Market by Procedure
5.1 Human Reproductive Technologies Market Snapshot and Growth Engine
5.2 Human Reproductive Technologies Market Overview
5.3 IVF with ICSI
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 IVF with ICSI: Geographic Segmentation Analysis
5.4 Egg/Sperm Donation
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Egg/Sperm Donation: Geographic Segmentation Analysis
5.5 Embryo Freezing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Embryo Freezing: Geographic Segmentation Analysis
5.6 Cryopreservation
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Cryopreservation: Geographic Segmentation Analysis
Chapter 6: Human Reproductive Technologies Market by Application
6.1 Human Reproductive Technologies Market Snapshot and Growth Engine
6.2 Human Reproductive Technologies Market Overview
6.3 Male Infertility
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Male Infertility: Geographic Segmentation Analysis
6.4 Female Infertility
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Female Infertility: Geographic Segmentation Analysis
6.5 Genetic Disorders
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Genetic Disorders: Geographic Segmentation Analysis
Chapter 7: Human Reproductive Technologies Market by End User
7.1 Human Reproductive Technologies Market Snapshot and Growth Engine
7.2 Human Reproductive Technologies Market Overview
7.3 Hospitals & Clinics
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospitals & Clinics: Geographic Segmentation Analysis
7.4 Fertility Centers
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Fertility Centers: Geographic Segmentation Analysis
7.5 Research Institutes
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Research Institutes: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Human Reproductive Technologies Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 ABBOTT (USA)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 EVOFEM BIOSCIENCES INC. (USA)
8.4 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
8.5 SUN PHARMACEUTICAL INDUSTRIES LTD. (INDIA)
8.6 PERRIGO COMPANY PLC. (IRELAND)
8.7 UNIPRIX (CANADA)
8.8 LUPIN (INDIA)
8.9 SANDOZ INTERNATIONAL GMBH (SWITZERLAND)
8.10 AUROBINDO PHARMA (INDIA)
8.11 BAYER AG (GERMANY)
8.12 LILLY (USA)
8.13 GSK PLC. (UK)
8.14 MANKIND PHARMA (INDIA)
8.15 CHURCH & DWIGHT CO. INC. (USA)
8.16 PFIZER INC. (USA)
8.17 OTHER ACTIVE PLAYERS
Chapter 9: Global Human Reproductive Technologies Market By Region
9.1 Overview
9.2. North America Human Reproductive Technologies Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Technology
9.2.4.1 Assisted Reproductive Technology (ART)
9.2.4.2 In Vitro Fertilization (IVF)
9.2.4.3 Surrogacy
9.2.4.4 Artificial Insemination
9.2.4.5 Genetic Testing
9.2.5 Historic and Forecasted Market Size By Procedure
9.2.5.1 IVF with ICSI
9.2.5.2 Egg/Sperm Donation
9.2.5.3 Embryo Freezing
9.2.5.4 Cryopreservation
9.2.6 Historic and Forecasted Market Size By Application
9.2.6.1 Male Infertility
9.2.6.2 Female Infertility
9.2.6.3 Genetic Disorders
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Hospitals & Clinics
9.2.7.2 Fertility Centers
9.2.7.3 Research Institutes
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Human Reproductive Technologies Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Technology
9.3.4.1 Assisted Reproductive Technology (ART)
9.3.4.2 In Vitro Fertilization (IVF)
9.3.4.3 Surrogacy
9.3.4.4 Artificial Insemination
9.3.4.5 Genetic Testing
9.3.5 Historic and Forecasted Market Size By Procedure
9.3.5.1 IVF with ICSI
9.3.5.2 Egg/Sperm Donation
9.3.5.3 Embryo Freezing
9.3.5.4 Cryopreservation
9.3.6 Historic and Forecasted Market Size By Application
9.3.6.1 Male Infertility
9.3.6.2 Female Infertility
9.3.6.3 Genetic Disorders
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Hospitals & Clinics
9.3.7.2 Fertility Centers
9.3.7.3 Research Institutes
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Human Reproductive Technologies Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Technology
9.4.4.1 Assisted Reproductive Technology (ART)
9.4.4.2 In Vitro Fertilization (IVF)
9.4.4.3 Surrogacy
9.4.4.4 Artificial Insemination
9.4.4.5 Genetic Testing
9.4.5 Historic and Forecasted Market Size By Procedure
9.4.5.1 IVF with ICSI
9.4.5.2 Egg/Sperm Donation
9.4.5.3 Embryo Freezing
9.4.5.4 Cryopreservation
9.4.6 Historic and Forecasted Market Size By Application
9.4.6.1 Male Infertility
9.4.6.2 Female Infertility
9.4.6.3 Genetic Disorders
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Hospitals & Clinics
9.4.7.2 Fertility Centers
9.4.7.3 Research Institutes
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Human Reproductive Technologies Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Technology
9.5.4.1 Assisted Reproductive Technology (ART)
9.5.4.2 In Vitro Fertilization (IVF)
9.5.4.3 Surrogacy
9.5.4.4 Artificial Insemination
9.5.4.5 Genetic Testing
9.5.5 Historic and Forecasted Market Size By Procedure
9.5.5.1 IVF with ICSI
9.5.5.2 Egg/Sperm Donation
9.5.5.3 Embryo Freezing
9.5.5.4 Cryopreservation
9.5.6 Historic and Forecasted Market Size By Application
9.5.6.1 Male Infertility
9.5.6.2 Female Infertility
9.5.6.3 Genetic Disorders
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Hospitals & Clinics
9.5.7.2 Fertility Centers
9.5.7.3 Research Institutes
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Human Reproductive Technologies Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Technology
9.6.4.1 Assisted Reproductive Technology (ART)
9.6.4.2 In Vitro Fertilization (IVF)
9.6.4.3 Surrogacy
9.6.4.4 Artificial Insemination
9.6.4.5 Genetic Testing
9.6.5 Historic and Forecasted Market Size By Procedure
9.6.5.1 IVF with ICSI
9.6.5.2 Egg/Sperm Donation
9.6.5.3 Embryo Freezing
9.6.5.4 Cryopreservation
9.6.6 Historic and Forecasted Market Size By Application
9.6.6.1 Male Infertility
9.6.6.2 Female Infertility
9.6.6.3 Genetic Disorders
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Hospitals & Clinics
9.6.7.2 Fertility Centers
9.6.7.3 Research Institutes
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Human Reproductive Technologies Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Technology
9.7.4.1 Assisted Reproductive Technology (ART)
9.7.4.2 In Vitro Fertilization (IVF)
9.7.4.3 Surrogacy
9.7.4.4 Artificial Insemination
9.7.4.5 Genetic Testing
9.7.5 Historic and Forecasted Market Size By Procedure
9.7.5.1 IVF with ICSI
9.7.5.2 Egg/Sperm Donation
9.7.5.3 Embryo Freezing
9.7.5.4 Cryopreservation
9.7.6 Historic and Forecasted Market Size By Application
9.7.6.1 Male Infertility
9.7.6.2 Female Infertility
9.7.6.3 Genetic Disorders
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Hospitals & Clinics
9.7.7.2 Fertility Centers
9.7.7.3 Research Institutes
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Human Reproductive Technologies Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 34.7 Billion |
|
Forecast Period 2024-32 CAGR: |
9.90% |
Market Size in 2032: |
USD 81.15 Billion |
|
Segments Covered: |
By Technology |
|
|
|
By Procedure |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
